Curcumin and nano-curcumin applications in psychiatric disorders

被引:0
|
作者
Mohammadzadeh, R. [1 ]
Fathi, M. [1 ]
Pourseif, M. M. [1 ]
Omidi, Y. [2 ]
Farhang, S. [3 ]
Jalali, M. Barzegar [1 ]
Valizadeh, H. [1 ]
Nakhlband, A. [3 ]
Adibkia, K. [1 ]
机构
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Nova Southeastern Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL USA
[3] Tabriz Univ Med Sci, Razi Psychiat Hosp, Res Ctr Psychiat & Behav Sci, Elgoli St,Block 2, Tabriz 5971919143, Iran
关键词
curcumin; nanocurcumin; psychiatric disorders; NF-KAPPA-B; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; BIPOLAR DISORDER; DOUBLE-BLIND; MAJOR DEPRESSION; AMYLOID-BETA; IN-VITRO; BRAIN; SCHIZOPHRENIA;
D O I
10.1002/ptr.8265
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Psychiatric disorders cause long-lasting disabilities across different age groups. While various medications are available for mental disorders, some patients do not fully benefit from them or experience treatment resistance. The pathogenesis of psychiatric disorders involves multiple mechanisms, including an increase in the inflammatory response. Targeting inflammatory mechanisms has shown promise as a therapeutic approach for these disorders. Curcumin, known for its anti-inflammatory properties and potential neuroprotective effects, has been the subject of studies investigating its potential as a treatment option for psychiatric disorders. This review comprehensively examines the potential therapeutic role of curcumin and its nanoformulations in psychiatric conditions, including major depressive disorder (MDD), bipolar disorder, schizophrenia, and anxiety disorders. There is lack of robust clinical trials across all the studied psychiatric disorders, particularly bipolar disorder and schizophrenia. More studies have focused on MDD. Studies on depression indicate that curcumin may be effective as an antidepressant agent, either alone or as an adjunct therapy. However, inconsistencies exist among study findings, highlighting the need for further research with improved blinding, optimized dosages, and treatment durations. Limited evidence supports the use of curcumin for bipolar disorder, making its therapeutic application challenging. Well-designed clinical trials are warranted to explore its potential therapeutic benefits. Exploring various formulations and delivery strategies, such as utilizing liposomes and nanoparticles, presents intriguing avenues for future research. More extensive clinical trials are needed to assess the efficacy of curcumin as a standalone or adjunctive treatment for psychiatric disorders, focusing on optimal dosages, formulations, and treatment durations. Curcumin and nano-curcumin applications for psychiatric disorders. image
引用
收藏
页码:4240 / 4260
页数:21
相关论文
共 50 条
  • [21] Novel delivery system for natural products: Nano-curcumin formulations
    Rahimi, Hamid Reza
    Nedaeinia, Reza
    Shamloo, Alireza Sepehri
    Nikdoust, Shima
    Oskuee, Reza Kazemi
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2016, 6 (04) : 383 - 398
  • [22] Curcumin nanoparticles and the therapeutic potential of curcumin for musculoskeletal disorders
    Wu, H. -y.
    Yu, H. -t.
    Kang, B.
    Xuan, Y. -y.
    Zhang, H. -q.
    Li, X. -s.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (20) : 9680 - 9702
  • [23] Nano-curcumin supplementation for the management of migraine: A systematic scoping review and meta-analysis
    Kontor, Ernest Kissi
    Muhammad, Daha Garba
    Kumah, Jessica
    Sackitey, Derrick
    Acheampong, Bismark
    Bortey, Godwin Odum
    Owusu, Bismark Osei
    Jain, Nityanand
    PHARMANUTRITION, 2024, 29
  • [24] The Effect of Nano-chitosan and Nano-curcumin on Radiated Parotid Glands of Albino Rats: Comparative Study
    Meabed, Omayma M.
    Shamaa, Ali
    Abdelrahman, Ibrahim Y.
    El-Sayyed, Gharieb S.
    Mohammed, Saher S.
    JOURNAL OF CLUSTER SCIENCE, 2023, 34 (02) : 977 - 989
  • [25] Evaluation of nano-curcumin against inhaled paraquat-induced lung injury in rats
    Ghasemi, Seyedeh Zahra
    Beigoli, Sima
    Behrouz, Sepideh
    Gholamnezhad, Zahra
    Roshan, Nema Mohammadian
    Boskabady, Mohammad Hossein
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 671 - 681
  • [26] Aerobic exercise and nano-curcumin supplementation improve inflammation in elderly females with metabolic syndrome
    Osali, Ali
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
  • [27] Evaluation of nano-curcumin against inhaled paraquat-induced lung injury in rats
    Seyedeh Zahra Ghasemi
    Sima Beigoli
    Sepideh Behrouz
    Zahra Gholamnezhad
    Nema Mohammadian Roshan
    Mohammad Hossein Boskabady
    Pharmacological Reports, 2023, 75 : 671 - 681
  • [28] Aerobic exercise and nano-curcumin supplementation improve inflammation in elderly females with metabolic syndrome
    Ali Osali
    Diabetology & Metabolic Syndrome, 12
  • [29] Study on the Application of a Novel Nano-Curcumin Drug for Alzheimer's Disease
    Yang, Liu
    Sun, Xin
    Huang, Jun
    Zhu, Shimiao
    Li, Yan
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (03) : 445 - 452
  • [30] The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: A systematic review
    Moutabian, Hossein
    Ghahramani-Asl, Ruhollah
    Mortezazadeh, Tohid
    Laripour, Reza
    Narmani, Asghar
    Zamani, Hamed
    Ataei, Gholamreza
    Bagheri, Hamed
    Farhood, Bagher
    Sathyapalan, Thozhukat
    Sahebkar, Amirhossein
    BIOFACTORS, 2022, 48 (03) : 597 - 610